The 2023 Aus CVD Risk calculator and guideline provide updated evidence-based recommendations for identifying, assessing, communicating and managing CVD risk in a primary prevention setting.

ATAGI flagged worrying vaccine coverage declines and renewed disease threats, with pharmacists tipped to boost community protection.

From 1 October 2026, COVID-19 vaccination will move from its pandemic-era funding model onto the NIPVIP program.

Healthy sleep requires a range of complex physiological processes to be aligned with the body’s circadian clock and matched to social and environmental contexts

Coming soon: Greater online access for pharmacists to pathology and diagnostic imaging reports, a crucial boost for patient safety.

Dealing with challenging situations and weighing up the best available evidence is a familiar scenario for medical professionals. But for Professor Brendan Murphy, who led the health response to the COVID-19 pandemic, the scope of the challenge – and the evidence — changed constantly.